thepharmaletter Article | 19 November 2010 The US Food and Drug Administration’s Vaccines and Related Biological Products Advisory Committee has advised that the data presented support an indication for drug giant Merck & Co’s (NYSE: MRK) Gardasil ([Human Papillomavirus Quadrivalent [Types 6, 11, 16, and 18] Vaccine, Recombinant) for the prevention of anal cancer and […]
Media sways support for HPV vaccine
Futurity November 18, 2010 U. MINNESOTA (US) — Controversy surrounding state laws that require young girls to be vaccinated against human papillomavirus diminishes public support for the vaccine. News coverage about HPV vaccine requirements tends to amplify the controversy, possibly leading to negative attitudes among the public about the value of the HPV vaccine or […]
Merck announces FDA Advisory Committee approval of GARDASIL for anal cancer and AIN treatment
The Medical News November 18, 2010 Merck announced today that the U.S. Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee has advised that the data presented support an indication for GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant] for the prevention of anal cancer and anal intraepithelial […]
Allan Hildesheim: Will the HPV Vaccine Reach Young Women in Developing Coun
Cancer Prevention 2008 Issue 10 Allan Hildesheim, Ph.D. Senior Investigator Division of Cancer Epidemiology and Genetics National Cancer Institute Rockville, Maryland With licensure of the first prophylactic human papillomavirus (HPV) vaccines, a new era in cervical cancer prevention has begun. The new vaccines add to the existing arsenal of prevention tools that can be used […]
GARDASIL® is First Cervical Cancer Vaccine to Receive WHO Pre-qualification
Merck Newsroom WHITEHOUSE STATION, N.J., May 26, 2009 – GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Vaccine, Recombinant], Merck’s cervical cancer vaccine, has been awarded World Health Organization (WHO) pre-qualification. GARDASIL is the first cervical cancer vaccine to receive WHO pre-qualification. WHO pre-qualification means that GARDASIL is now eligible for procurement by the United […]
- « Previous Page
- 1
- …
- 202
- 203
- 204
- 205
- 206
- …
- 240
- Next Page »